CD274 and neoplasm: The proliferation of peripheral T cells after PD-1/PDL1 inhibitor treatment can promote more peripheral T cells to enter the tumor microenvironment, increase the number of tumor-infiltrating T cells and improve tumor immune infiltration, possibly transforming “cold tumors” into “hot tumors“ [17].